Second Quarter 2023 Earnings Call

DRI Healthcare Announces Exercise of Put Option on EKTERLY®

DRI Healthcare Comments on Viridian's FDA Approval and Launch of Lumvoa™ (veligrotug-vvze)

2026 Annual and Special Meeting of Unitholders